Clinical trial
Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo
NCT03365141 is registered in ClinicalTrials.gov with The Catholic University of Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo
- Lead sponsor
- The Catholic University of Korea
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 14, 2017
- Completion date
- September 15, 2018
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
corticosteroid, intralesional injection, treatment, vitiligo